RDGT
Ridgetech Inc.NASDAQHealthcare$0.02-25.61%ClosedMarket Cap: $144,038
As of 2026-04-06
Valuation
P/E (TTM)
0.02
PEG
0.00
P/B
0.00
P/S
0.00
EV/EBITDA
-1.38
DCF Value
$-29.29
FCF Yield
4989.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
-7.4%
Operating Margin
1.1%
Net Margin
11.1%
ROE
41.8%
ROA
20.2%
ROIC
2.2%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 2026 | $62.8M | 3.9% | $74.3K | $-60.2K | $-0.01 | — |
| Q4 2025 | $48.8M | -22.0% | $1.2M | $12.5M | $2.26 | — |
| FY 2025 | $120.0M | 3.2% | $-1.0M | $10.2M | $1.84 | — |
| Q2 2025 | $71.2M | 20.5% | $-2.2M | $-2.3M | $-0.42 | — |
| Q4 2024 | $76.0M | 20.0% | $-3.8M | $-3.3M | $-1.96 | — |
| FY 2024 | $154.5M | 20.1% | $-3.5M | $-4.2M | $-2.93 | — |
| Q2 2024 | $78.6M | 20.3% | $256.0K | $-924.0K | $-0.78 | — |
| Q4 2023 | $76.1M | 22.8% | $-19.7M | $-20.5M | $-25.90 | — |
| FY 2023 | $148.8M | 23.0% | $-20.9M | $-21.1M | $-41.46 | — |
| Q2 2023 | $72.7M | 23.3% | $-1.2M | $-594.8K | $-2.62 | — |
| Q4 2022 | $85.9M | 24.6% | $-2.2M | $-2.9M | $-16.84 | — |
| FY 2022 | $164.4M | 22.2% | $-2.7M | $-3.2M | $-18.35 | — |